Physician profile
David Yonick
NPI 1568626752
$700.38
in general payments reported to CMS, 2019-2025
10 companies · $97.39 in 2025
The $97.39 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $208 · 2021: $108 · 2022: $58.72 · 2023: $15.72 · 2024: $70.54 · 2025: $97.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $183.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $184.32 | 2019-2022 | |
| Galderma Laboratories, L.P. | $150.00 | 2020 | |
| Mentor Worldwide LLC | $96.19 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Sientra, INC. | $73.22 | 2021-2022 | |
| Rti Surgical, INC | $60.86 | 2024-2025 | |
| Ethicon US, LLC | $39.68 | 2025 | Vistaseal |
| Abbvie INC. | $34.75 | 2023-2024 | Natrelle Saline-Filled Breast Implants |
| Solventum Corporation | $23.96 | 2024 | Prevena |
| Tepha INC | $22.35 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $15.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Yonick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.